IRBT · As filed with the SEC
Irobot cash flow statement, by fiscal year
The statement as Irobot presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD thousands
| USD thousands | FY2024 Year ended Dec 28, 2024 | FY2023 Year ended Dec 30, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Jan 1, 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | (145,518) | (304,710) | (286,295) | 30,390 |
| Adjustments to reconcile net loss to net cash provided in operating activities: | ||||
| Depreciation and amortization | 21,667 | 32,791 | 47,869 | 33,309 |
| Loss on equity investment | (370) | (3,910) | (19,718) | 30,063 |
| Stock-based compensation | 24,476 | 36,056 | 31,905 | 21,694 |
| Provision for inventory excess and obsolescence | 13,489 | — | — | — |
| Change in fair value of term loan | 24,557 | 5,904 | — | — |
| Debt issuance costs expensed under fair value option | 583 | 11,837 | — | — |
| Deferred income taxes, net | (2,391) | 6,563 | 18,799 | (6,934) |
| Other | (4,140) | (17,694) | (1,003) | 5,940 |
| Changes in operating assets and liabilities — (use) source, excluding effects of acquisition | ||||
| Accounts receivable | 27,122 | (11,748) | 94,750 | 10,290 |
| Inventory | 58,952 | 125,710 | 49,399 | (151,193) |
| Other assets | 21,966 | 13,941 | 52,029 | (19,868) |
| Accounts payable | (70,970) | (4,604) | (73,598) | 82,289 |
| Accrued expenses and other liabilities | (3,385) | (12,749) | (43,594) | (7,824) |
| Net cash used in operating activities | (33,222) | (114,793) | (90,021) | (31,970) |
| Cash flows from investing activities: | ||||
| Additions of property and equipment | (118) | (2,862) | (12,325) | (29,928) |
| Purchase of investments | (136) | (233) | (3,150) | (10,811) |
| Proceeds from sale of equity investments | — | — | — | 0 |
| Cash paid for business acquisition, net of cash acquired | — | 0 | 0 | (71,357) |
| Sales and maturities of investments | 0 | 0 | 17,723 | 63,976 |
| Net cash (used in) provided by investing activities | (254) | (3,095) | 2,248 | (48,120) |
| Cash flows from financing activities: | ||||
| Proceeds from employee stock plans | 0 | 9 | 4,719 | 6,719 |
| Income tax withholding payment associated with restricted stock vesting | (507) | (2,802) | (1,775) | (5,161) |
| Stock repurchases | — | 0 | 0 | (150,000) |
| Proceeds from issuance of common stock, net of issuance costs | 19,297 | — | — | — |
| Repayment of term loan | (34,947) | — | — | — |
| Proceeds from term loan | 0 | 200,000 | — | — |
| Payment of debt issuance costs | (583) | (11,837) | — | — |
| Net cash (used in) provided by financing activities | (16,740) | 185,370 | 2,944 | (148,442) |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | (2,646) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 280 | 2,456 | 1,321 | — |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (49,936) | 69,938 | (83,508) | (231,178) |
| Cash, cash equivalents and restricted cash at beginning of period | 187,887 | 117,949 | 201,457 | 432,635 |
| Cash, cash equivalents and restricted cash, at end of period | 137,951 | 187,887 | 117,949 | 201,457 |
| Supplemental disclosure of cash flow information | ||||
| Cash paid for income taxes, net of refunds | 0 | 6,117 | 8,489 | 20,375 |
| Cash paid for interest | 22,386 | 6,522 | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.